Adenovirus type 4 a
Ended Awarded
- Contract number
- SPE2DP25F9617
- Awardee
-
Teva Pharmaceuticals Usa, Inc. UEI NEN9A34LRHJ5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $825,785
Award facts
- Contract value 100% obligated
- $825,784.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Parsippany, NJ 07054, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Troop Support Medical awarded a delivery order valued at $825,784.65 to Teva Pharmaceuticals USA, Inc. for Adenovirus Type 4 vaccine, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was awarded without a set-aside designation on July 14, 2025, and will be performed at Teva's facility in Parsippany, New Jersey. Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd., serves as a critical supplier of pharmaceutical products to multiple federal agencies including the Department of Defense, Veterans Affairs, Bureau of Prisons, and Indian Health Service.
This delivery order supports military immunization programs as part of the Department of Defense's Medical Supply Chain operations. Teva's award reflects its established position as a reliable large business vendor capable of supplying high-volume pharmaceutical products with precision. The company maintains significant federal pharmaceutical supply relationships through multiple indefinite delivery contracts, including a $64.4 million contract with the Veterans Affairs National Acquisition Center and a $5.7 million contract with the Defense Logistics Agency, demonstrating its strategic importance to federal healthcare systems and military readiness.
Quick answers
Who was awarded contract SPE2DP25F9617?
SPE2DP25F9617 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on July 14, 2025.
How much is contract SPE2DP25F9617 worth?
The government has obligated $825,785 on SPE2DP25F9617.
Is contract SPE2DP25F9617 an order under another contract?
Yes. SPE2DP25F9617 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.
Was contract SPE2DP25F9617 competed?
The extent of competition for SPE2DP25F9617 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award